The New Antiepileptic Drugs, Clinical Applications
JAMA 291:615-620, LaRoche,S.M.&Helmers,S.L., 2004
Epilepsy
JAMA 291:654, Parmet,S, 2004
Brain Metastases
The Neurologist 10:31-46, Klos,K.J.&O'Neill,B.P., 2004
Lateralizing Value of Todd's Palsy in Patients with Epilepsy
Neurol 62:289-291, Kellinghaus,C.&Kotagal,P., 2004
Specificity of Barkhof Criteria in Predicting Conversion to Multiple Sclerosis When Applied to Clinically Isolated Brainstem Syndromes
Arch Neurol 61:222-224, Sastre-Garriga,J.,et al, 2004
Postpartum Angiopathy with Reversible Posterior Leukoencephalopathy
Arch Neurol 61:411-416, Singhal,A.B., 2004
Cognitive Side Effects of Antiepileptic Drugs in Children
Neurol 62:872-877, Loring,D.W.&Meador,K.J., 2004
Acute Aphasia in Multiple Sclerosis, A Multicenter Study of 22 Patients
Neurol 62:974-977, Lacour,A.,et al, 2004
The AED (Antiepileptic Drug) Pregnancy Registry
Arch Neurol 61:673-678, Holmes,L.B.,et al, 2004
Meningiomas
Lancet 363:1535-1543, Whittle,I.R.,et al, 2004
Magnetic Resonance Imaging Abnormalities with Septic Encephalopathy
JNNP 75:1189-1191, Finelli,P.F. &Uphoff,D.F., 2004
Magnetoencephalography (MEG) and Magnetic Source Imaging (MSI)
The Neurologist 10:138-153, Wheless,J.W.,et al, 2004
Practice Parameter: Medical Treatment of Infantile Spasms
Neurol 62:1668-1681, Mackay,M.T.,et al, 2004
Cerebral Hemispherectomy
Neurol 62:1712-1721,1664, Jonas,R.,et al, 2004
Calcific Neurocysticercosis and Epileptogenesis
Neurol 62:1934-1938, Nash,T.E.,et al, 2004
Levetiracetam in the Treatment of Idiopathic Hemifacial Spasm
Neurol 62:2134-2135, Deleu,D., 2004
Marijuana Use and Epilepsy
Neurol 62:2095-2097, Gross,D.W.,et al, 2004
Neurosyphilis with Complex Partial Status Epilepticus and Mesiotemporal MRI Abnormalities Mimicking herpes Simplex Encephalitis
JNNP 75:833, Marano,E.,et al, 2004
Flavivirus Encephalitis
NEJM 351:370-378, Solomon,T., 2004
MMR Vaccination and Febrile Seizures
JAMA 292:351-357, Vestergaard,M.,et al, 2004
Vacuum Cleaner Epilepsy
Neurol 63:190-191, Carlson,C. &St. Louis,E.K., 2004
Ictal Stuttering
Neurol 63:516-519, Vossler,D.G.,et al, 2004
Role of Magnetic Resonance Imaging Within Diagnostic Criteria for Multiple Sclerosis
Ann Neurol 56:273-278, Miller,D.H.,et al, 2004
The Neurological Complications of Bariatric Surgery
Arch Neurol 61:1185-1189, Berger,J.R., 2004
Seizure Outcomes After Stereotactic Radiosurgery for Cerebral Arteriovenous Malformations
Neurol 63:683-687, Schauble,B.,et al, 2004
Monotherapy in Epilepsy
Arch Neurol 61:1361-1365, Vazquez,B., 2004
Diffusion-Weighted and Conventional MR Imaging Findings of Neuroaxonal Dystrophy
AJNR 25:1269-1273, Sener,R.N., 2004
Interferon Beta-1a for Brain Tissue Loss in Patients at Presentation with Syndromes Suggestive of Multiple Sclerosis: A Randomised, Double-Blind, Placebo-Controlled Trial
Lancet 364:1489-1496,1463, Filippi,M.,et al, 2004
Clinicopath Conf, Anaplastic Oligodendroglioma with Allelic Loss of Chromosomes 1p and 19q
NEJM 351:1875-1882, Case 33-2004, 2004
Rapid Infusion with Valproate Sodium is Well Tolerated in Patients with Epilepsy
Neurol 63:1507-1508, Wheless,J.W.,et al, 2004
Lower Phenytoin Serum Levels in Persons Switched from Brand to Generic Phenytoin
Neurol 63:1494-1496, Burkhardt,R.T.,et al, 2004
Long-Term Brain Magnetic Resonance Imaging Changes After Optic Neuritis in Patients Without Clinically Definite Multiple Sclerosis
Arch Neurol 61:1538-1541, Optic Neuritis Study Group, 2004
Intravenous Immunoglobulin Treatment Following the First Demyelinating Event Suggestive of Multiple Sclerosis
Archn Neurol 61:1515-1520, Achiron,A.,et al, 2004
Mortality in Epilepsy: Driving Fatalities vs Other Causes of Death in Patients with Epilepsy
Neurol 63:1002-1007, Sheth,S.G.,et al, 2004
Post-Stroke Movement Disorders; Report of 56 Patients
JNNP 75:1568-1574, Alarcon,F.,et al, 2004
Neonatal Brain Injury
NEJM 351:1985-1995, Ferriero,D.M., 2004
Injuries Due to Seizures in Persons with Epilepsy
Neurol 63:1565-1570, Lawn,N.D.,et al, 2004
The United Kingdom Infantile Spasms Study Comparing Vigabatrin with Prednisolone or Tetracosactide at 14 Days: A Multicentre, Randomised Controlled Trial
Lancet 364:1773-1778, Lux,A.L.,et al, 2004
Clinically Mild Encephalitis Encephalopathy with a Reversible Splenial Lesion
Neurol 63:1854-1858, Tada,H.,et al, 2004
Epileptic Seizures in Systemic Lupus Erythematosus
Neurol 63:1808-1812, Appenzeller,S.,et al, 2004
Natural History of Nonketotic Hyperglycinemia in 65 Patients
Neurol 63:1847-1853, Hoover-Fong,J.E.,et al, 2004
MR Spectroscopy in the Diagnosis of Cerebral Amyloid Angiopathy Presenting as a Brain Tumor
AJNR 25:1705-1708, Safriel,Y.,et al, 2004
Parenchymal Abnormalities Associated with Cerebral Venous Sinus Thrombosis: Assessment with Diffusion-Weighted MR Imaging
AJNR 25:1666-1675, Mullins,M.E.,et al, 2004
Clinical Manifestations of Cerebral Amyloid Angiopathy-Related Inflammation
Ann Neurol 55:250-256, Eng,J.A.,et al, 2004
Potassium Channel Antibody-Associated Encephalopathy: A Potentially Immunotherapy-Responsive Form of Limbic Encepahlitis
Brain 127:701-712, Vincent,A.,et al, 2004
Potentially Reversible Autoimmune Limbic ncephalitis with Neuronal Potassium Channel Antibody
Neurol 62:1177-1182,1040, Thieben,M.J.,et al, 2004
Imaging Manifestations of Neurosarcoidosis
AJR 182:289-295, Smith, J.K.,et al, 2004
Reversible Corpus Callosum Lesion in Legionnaires Disease
JNNP 75:651-654, Morgan, J.C.,et al, 2004
Mutations in the Molybdenum Cofactor Biosynthetic Genes MOCS1, MOCS2, and GEPH
Hum Mutat 21:569-576, Reiss,J. &Johnson,J.L., 2003
Diffusion-Weighted Imaging Abnormalities in the Splenium After Seizures
Epilepsia 44:852-854, Oster,J.,et al, 2003